| 000 | 01741 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517132421.0 | ||
| 264 | 0 | _c20170803 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2016.12.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Rosa, Maria | |
| 245 | 0 | 0 |
_aDesign, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB). _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _c02 2017 |
||
| 300 |
_a897-911 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEscherichia coli _xenzymology |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOligopeptides _xchemical synthesis |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aLu, Lu | |
| 700 | 1 | _aZamaratski, Edouard | |
| 700 | 1 | _aSzałaj, Natalia | |
| 700 | 1 | _aCao, Sha | |
| 700 | 1 | _aWadensten, Henrik | |
| 700 | 1 | _aLenhammar, Lena | |
| 700 | 1 | _aGising, Johan | |
| 700 | 1 | _aRoos, Annette K | |
| 700 | 1 | _aHuseby, Douglas L | |
| 700 | 1 | _aLarsson, Rolf | |
| 700 | 1 | _aAndrén, Per E | |
| 700 | 1 | _aHughes, Diarmaid | |
| 700 | 1 | _aBrandt, Peter | |
| 700 | 1 | _aMowbray, Sherry L | |
| 700 | 1 | _aKarlén, Anders | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 25 _gno. 3 _gp. 897-911 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2016.12.003 _zAvailable from publisher's website |
| 999 |
_c26743268 _d26743268 |
||